Inflammation and delayed endothelization with overlapping drug-eluting stents in a porcine model of in-stent restenosis

Circulation Journal

Volumn 72, Issue 3, 2008, Pages 463-468

  Sang, Yup Lim ^a   Myung, Ho Jeong ^b   Soon, Jun Hong ^a   Do, Sun Lim ^a   Jae, Youn Moon ^b   Young, Joon Hong ^b   Ju, Han Kim ^b   Ahn, Youngkeun ^b   Jung, Chaee Kang ^b  

^a Korea University College of Medicine   (South Korea)

^b Chonnam National University Medical School   (South Korea)

Author keywords

Coronary disease; Drug eluting stent; Restenosis; Stent thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; PACLITAXEL; RAPAMYCIN;

ANGIOCARDIOGRAPHY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY DIAMETER; ARTERY INTIMA PROLIFERATION; ARTICLE; CONTROLLED STUDY; DRUG ELUTING STENT; EXPERIMENTAL MODEL; FOLLOW UP; HISTOPATHOLOGY; IN-STENT RESTENOSIS; INFLAMMATION; INTIMA; LEFT ANTERIOR DESCENDING CORONARY ARTERY; NONHUMAN; SWINE;

ANIMALS; CELL PROLIFERATION; CORONARY RESTENOSIS; CORONARY STENOSIS; CORONARY VESSELS; DISEASE MODELS, ANIMAL; DRUG-ELUTING STENTS; ENDOTHELIUM, VASCULAR; FEMALE; HYPERPLASIA; INFLAMMATION; PACLITAXEL; SIROLIMUS; STENTS; SWINE; TUNICA INTIMA;

EID: 42649132166     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.72.463     Document Type: Article

References (25)

1. Serruys PW, Foley DP, Suttorp MJ, Rensing BJ, Suryapranata H, Materne P, et al. A randomized comparison of the value of additional stenting after optimal balloon angioplasty for long coronary lesions: Final results of the additional value of NIR stents for treatment of long coronary lesions (ADVANCE) study. J Am Coll Cardiol 2002; 39: 393-399.
2. Oemrawsingh PV, Mintz GS, Schalij MJ, Zwinderman AM, Jukema JW, Van der Wall EE, et al. Intravascular ultrasound guidance improves angiographic and clinical outcome of stent implantation for long coronary artery stenoses: Final results of a randomized comparison with angiographic guidance (TULIP Study). Circulation 2003; 107: 62-67.
3. Kornowski R, Bhargava B, Fuchs S, Lansky AJ, Satler LF, Pichard AD, et al. Procedural results and late clinical outcomes after percutaneous interventions using long (≥25 mm) versus short (<20 mm) stents. J Am Coll Cardiol 2000; 35: 612-618.
4. Kastrati A, Elezi S, Dirschinger J, Hadamitzky M, Neumann F, Schomig A. Influence of lesion length on restenosis after coronary stent placement. Am J Cardiol 1999; 83: 1617-1622.
5. Kornowski R, Mehran R, Hong MK, Satler LF, Pichard AD, Kent KM, et al. Procedural results and late clinical outcomes after placement of three or more stents in single coronary lesions. Circulation 1998; 97: 1355-1361.
6. Finn AV, Kolodgie FD, Harnek J, Guerrero LJ, Acampado E, Tefera K et al. Differential response of delayed healing and persistent inflammation at sites of overlapping sirolimus- or paclitaxel-eluting stents. Circulation 2005; 112: 270-278.
7. Ahn YK, Jeong MH, Kim JW, Kim SH, Cho JH, Cho JG, et al. Preventive effects of heparin coated stent on restenosis in the porcine model. Catheter Cardiovasc Intern 1999; 48: 324-330.
8. Schwartz RS, Huber KC, Murphy JG, Edwards WD, Camrud AR, Vlietstra RE, et al. Restenosis and the proportional neointimal response to coronary artery injury: Results in a porcine model. J Am Coll Cardiol 1992; 19: 267-274.
9. Schalij MJ, Udayachalerm W, Oemrawsingh P, Jukema JW, Reiber JH, Bruschke AV. Stenting of long coronary artery lesions: Initial angiographic results and 6-month clinical outcome of the micro stent II-XL. Catheter Cardiovasc Interv 1999; 48: 105-112.
10. Nebeker JR, Virmani R, Bennett CL, Hoffman JM, Samore MH, Alvarez J, et al. Hypersensitivity cases associated with drug-eluting coronary stents: A review of available cases from the Research on Adverse Drug Events and Reports (RADAR) project. J Am Coll Cardiol 2006; 47: 175-181.
11. Virmani R, Farb A, Guagliumi G, Kolodgie FD. Drug-eluting stents: Caution and concerns for long-term outcome. Coron Artery Dis 2004; 15: 313-318.
12. Azarbal B, Currier JW. Allergic reactions after the implantation of drug-elutine stents: Is it the pill or the polymer? J Am Coll Cardiol 2006; 47: 182-183.
13. Balakrishnan B, Tzafriri AR, Seifert P, Groothuis A, Rogers C, Edelman ER. Strut position, blood flow, and drug deposition: Implications for single and overlapping drug-eluting stents. Circulation 2005; 111: 2958-2965.
14. Babinska A, Markell MS, Salifu MO, Akoad M, Ehrlich YH, Kornecki E. Enhancement of human platelet aggregation and secretion induced by rapamycin. Nephrol Dial Transplant 1998; 13: 3153-3159.
15. Stone GW, Ellis SG, Cox DA, Hermiller J, O'Shaughnessy C, Mann JT, et al. One-year clinical results with the slow-release, polymerbased, paclitaxel-eluting TAXUS stent: The TAXUS-IV trial. Circulation 2004; 109: 1942-1947.
16. Luscher TF, Steffel J, Eberli FR, Joner M, Nakazawa G, Tanner FC, et al. Drug-eluting stent and coronary thrombosis: Biological mechanisms and clinical implications. Circulation 2007; 115: 1051-1058.
17. Takahashi S, Kaneda H, Tanaka S, Miyashita Y, Shiono T, Taketani Y, et al. Late angiographic stent thrombosis after sirolimus-eluting stent implantation. Circ J 2007; 71: 226-228.
18. Urban P, De Benedetti E. Thrombosis: The last frontier of coronary stenting? Lancet 2007; 369: 619-621.
19. Ishikawa T, Mutoh M, Fuda Y, Sakamoto H, Okada H, Higashitani M, et al. Documented subacute stent thrombosis within thirty days after stenting with sirolimus-eluting stent (Cypher) for acute myocardial infarction: A Japanese single center retrospective non-randomized study. Circ J 2006; 70: 1091-1092.
20. Cutlip DE, Baim DS, Ho KK, Popma JJ, Lansky AJ, Cohen DJ, et al. Stent thrombosis in the modern era: A pooled analysis of multicenter coronary stent clinical trials. Circulation 2001; 103: 1967-1971.
21. Ong AT, McFadden EP, Regar E, de Jaegere PP, van Domburg RT, Serruys PW. Late angiographic stent thrombosis (LAST) events with drug-eluting stents. J Am Coll Cardiol 2005; 45: 2088-2092.
22. McFadden EP, Stabile E, Regar E, Cheneau E, Ong AT, Kinnaird T, et al. Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet 2004; 364: 1519-1521.
23. Kim W, Jeong MH, Cha KS, Hyun DW, Hur SH, Kim KB, et al. The effect of anti-oxidants (carvedilol and probucol) loaded stents in a porcine coronary restenosis model. Circ J 2005; 69: 101-106.
24. Hong YJ, Jeong MH, Kim W, Lim SY, Lee SH, Hing SN, et al. Effect of abciximab-coated stent on in-stent intimal hyperplasia in human coronary arteries. Am J Cardiol 2004; 94: 1050-1054.
25. Kim W, Jeong MH, Kim KH, Sohn IS, Hong YS, park HW, et al. The clinical results of a platelet glycoprotein IIb/IIIa receptor blocker (abciximab: ReoPro)-coated stent in acute myocardial infarction. J Am Coll Cardiol 2006; 47: 933-938.